4-(Ethylamino)-4-piperidinecarboxamide(CAS: 84100-54-9)

CAS Number
Related Products
2-Methoxy-4-methyl-5-nitropyridine
CAS Number: 6635-90-1
1-(4-Hydroxyphenyl)-1-propanone
CAS Number: 70-70-2
3-Fluoropyridine
CAS Number: 372-47-4
Methyl 5-bromo-2-chlorobenzoate
CAS Number: 251085-87-7
Other Suppliers for 4-(Ethylamino)-4-piperidinecarboxamide
Basic Information
Molecular Formula
C8H17N3O
Molecular Weight
171.24 g/mol
Physical Properties
Boiling Point
351.7°C at 760 mmHg
Density
1.07±0.1 g/cm3 (20 ºC 760 Torr),
Flash Point
166.5°C
Chemical Identifiers
SMILES
CCNC1(CCNCC1)C(=O)N
InChIKey
AVEQCXBQACLXDJ-UHFFFAOYSA-N
Database References
MDL Number
MFCD00087130
FAQ
4-(Ethylamino)-4-piperidinecarboxamide (CAS: 84100-54-9) falls under the regulation of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and is classified as a skin and eye irritant. It also adheres to the European Chemicals Agency (ECHA) regulations under REACH. For FDA and EPA requirements, it is considered a pharmaceutical intermediate and may be subject to specific handling and disposal guidelines depending on its intended use.
Several alternatives to 4-(Ethylamino)-4-piperidinecarboxamide can be used in synthesis, including 4-(Methylamino)-4-piperidinecarboxamide and 4-(Butylamino)-4-piperidinecarboxamide. These analogs can provide similar functional groups and can be synthesized using similar reagents and conditions, but they may have different properties and applications depending on the desired end-product.
4-(Ethylamino)-4-piperidinecarboxamide has seen growing interest in the pharmaceutical and biotechnology sectors due to its potential as a therapeutic agent. Research trends include its use in developing treatments for various diseases, such as inflammatory conditions and pain management. The market is expected to grow with increasing demand from these applications, and there is ongoing research to explore its full potential.
Waste containing 4-(Ethylamino)-4-piperidinecarboxamide (CAS: 84100-54-9) should be collected in appropriate containers and disposed of according to local environmental regulations. For safe disposal, it is recommended to incinerate the waste or use a professional waste disposal service that can handle pharmaceutical intermediates safely. Proper precautions should be taken to prevent environmental contamination during waste handling and disposal.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Manager Zhang
supplychain@witofly.com



![N-[4-(4-Fluorophenyl)-5-(hydroxymethyl)-6-isopropyl-2-pyrimidinyl]-N-methylmethanesulfonamide](https://static.chemtradehub.com/structs/147/147118-36-3-8396.webp)





![5-Chloro-3-nitropyrazolo[1,5-a]pyrimidine](https://static.chemtradehub.com/structs/136/1363380-51-1-6292.webp)





